Sol J. Barer, Director at NexImmune, Inc. (NEXI), bought 60,000 shares at $2.11 ($127K) on 2022-03-18, disclosed to the SEC on 2022-03-21.
Open-market purchase of $127k NEXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.11 | 30,000 | $63K | 50.0% |
| 2 | $2.11 | 30,000 | $63K | 50.0% |
| Total | $2.11 avg | 60,000 | $127K | 100% |
| Filing → |
| NEXI | BUY | 2022-06-02 | $312K | — | Filing → |
| NEXI | BUY | 2022-03-24 | $27K | — | Filing → |
| NEXI | BUY | 2022-03-23 | $72K | — | Filing → |